Cargando…
Hematologic Relapse after 2 Years on a Non-Authorized Copy Version of Imatinib in a Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report
Imatinib (Gleevec®/Glivec®) has demonstrated high and durable hematologic and cytogenetic response rates, favorable safety and toxicity profiles, and prolonged survival when used for the treatment of chronic myeloid leukemia (CML). Imatinib copy drugs are currently available in some countries; howev...
Autor principal: | Chouffai, Zoubir |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2968768/ https://www.ncbi.nlm.nih.gov/pubmed/21045935 http://dx.doi.org/10.1159/000319150 |
Ejemplares similares
-
Two Ocular Infections during Conventional Chemotherapy in a Patient with Acute Lymphoblastic Leukemia: A Case Report
por: Taha, Ruba, et al.
Publicado: (2010) -
A Case of Multiple Pilosebaceous Cysts
por: Yoshida, Masuki, et al.
Publicado: (2010) -
Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention
por: Ohkoshi, Shogo, et al.
Publicado: (2010) -
Diabetic Mastopathy: A Case Report and Literature Review
por: Neetu, G., et al.
Publicado: (2010) -
A Case of Orbital Xanthogranuloma Treated by Surgical Excision
por: Shimizu, Fumiaki, et al.
Publicado: (2010)